RBC Capital Initiates Cidara Therapeutics(CDTX.US) With Buy Rating, Announces Target Price $34

Futu NewsDec 13 19:33 · Ratings

RBC Initiates Cidara Therapeutics at Outperform, Speculative Risk, With $34 Price Target

MT NewswiresDec 13 19:24 · Ratings

WBB Securities Initiates Cidara Therapeutics(CDTX.US) With Buy Rating, Announces Target Price $45

Futu NewsDec 6 01:31 · Ratings

WBB Securities Maintains Strong Buy on Cidara Therapeutics, Raises Price Target to $45

BenzingaDec 5 23:02 · Ratings

Cidara Therapeutics Analyst Ratings

BenzingaDec 5 22:59 · Ratings

Express News | Cidara Therapeutics Completes Enrollment of Phase 2B Navigate Trial Evaluating Cd388 for Prevention of Seasonal Influenza

BreakingsDec 4 21:00